Pressure Bio Cuts Q2 Net Loss as Total Revenues Dip, Product Sales Climb | GenomeWeb

NEW YORK (GenomeWeb) – Pressure BioSciences reported Thursday that its total revenues for the second quarter fell 14 percent year over year, though its product sales were up 56 percent. It also trimmed its net loss for the quarter.

The South Easton, Mass.-based maker of sample preparation tools brought in total revenues of $307,464 for the three months ended June 30, down from $357,736 for the second quarter of 2013. Revenues from the previous year included $161,214 in grant revenue not recognized in the most recent quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.